There we go. It’s here. President Donald Trump agreed to a phase-one trade deal with China, averting the Dec 15 introduction of new tariffs on $160 billion worth of Chinese goods.
If you've been around this joint for a while, you'll have seen us arguing folks would be silly to invest in MedMen (MMEN.C) if hanging on to your money is a thing you aspire to do. That's not because we have a hate on for the dude-bros running the show, or because they're not a client, or because we're short sellers, or any of the other 50 or so reasons MedMen homers have thrown at us over the last few years as a rationale for us not seeing the company in the same rose-coloured way they do. It's because MedMen is, and has always been, shit.
Technology public markets newbie AMPD Ventures (AMPD.C) has had an interesting first 7 weeks on the market, initially doubling in value out of the gate, before profit taking and short selling drove it well down to 2/3 of its initial financing price in just as quick time.
Whatever your feelings about Brazillian President Jair Bolsonaro, his plan to increase total infrastructure investment through partnerships or privatization seems to be bearing fruit. The Brazil government’s plan to boost the economy through doubling investment in infrastructure to approximately $65 million has drawn some attention from companies sniffing out ways to pad out their bottom line.